Literature DB >> 24820198

Evaluating the attendance of medical staff and room occupancy during palliative radiotherapy.

Irenäus A Adamietz1, Oliver Micke, Wolfgang Popp, Horst Sack.   

Abstract

INTRODUCTION: Attendance of staff and use of resources during treatment have an impact on costs. For palliative radiotherapy, no reliable data are available on the subject. Therefore, the measurement of selected variables (staff absorbance and room occupancy) based on daily palliative irradiation was the aim of our prospective study. The analysis is part of a larger study conducted by the German Society of Radiation Oncology (DEGRO). PATIENTS, MATERIAL, AND METHODS: A total of 172 palliative radiation treatments were followed up prospectively between October 2009 and March 2010. The study was performed at two experienced radiotherapy departments (Herne and Bielefeld) and evaluated the attendance of medical personnel and room occupancy related to the selected steps of the treatment procedure: treatment planning and daily application of radiation dose.
RESULTS: Computed tomography for treatment planning engaged the unit for 19 min (range: 17-22 min). The localization of target volume required on average 28 min of a technician's working time. The mean attendance of the entire staff (radiation oncologist, physicist, technician) for treatment planning was 159 min, while the total room occupancy was 140 min. Depending on the type of treatment, the overall duration of a radiotherapy session varied on average between 8 and 18 min. The staff was absorbed by the first treatment session (including portal imaging) for 8-27 min. Mean room occupancy was 18 min (range: 6-65 min). The longest medical staff attendance was observed during an initial irradiation session (mean: 11 min). Radiotherapy sessions with weekly performed field verifications occupied the rooms slightly longer (mean: 10 min, range: 4-25 min) than daily radiotherapy sessions (mean: 9 min, range: 3-29 min). We observed that the patients' symptoms, their condition, and their social environment confounded the time schedule.
CONCLUSIONS: Target localization, treatment planning, and performance of palliative radiotherapy absorb resources to an extent comparable to nonpalliative treatment. Because of unexpected events, the time schedule before and during radiotherapy may reveal strong interindividual variability.

Entities:  

Mesh:

Year:  2014        PMID: 24820198     DOI: 10.1007/s00066-014-0671-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  22 in total

1.  Costs of radiotherapy.

Authors:  Anders Norlund
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

2.  Radiotherapy in oncological emergencies--final results of a patterns of care study in Germany, Austria and Switzerland.

Authors:  Elmar Christian; Irinaeus A Adamietz; Normann Willich; Ulrich Schäfer; Oliver Micke
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

3.  Does this work for you? Individuals, averages, and evidence based medicine.

Authors:  Andrew Moore; Sebastian Straube; Sheena Derry; Henry McQuay
Journal:  BMJ       Date:  2008-11-19

Review 4.  Palliative radiation therapy.

Authors:  M P Richter; L R Coia
Journal:  Semin Oncol       Date:  1985-12       Impact factor: 4.929

5.  [Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

Authors:  A Zabel-du Bois; S Milker-Zabel; M Henzel; W Popp; J Debus; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2012-08-01       Impact factor: 3.621

6.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial.

Authors:  E Blank; N Willich; R Fietkau; W Popp; J Schaller-Steiner; H Sack; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-01-14       Impact factor: 3.621

7.  Treating the patient, not just the cancer.

Authors:  I F Tannock
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245

8.  Results of a nationwide survey on radiotherapy of bone metastases in Germany.

Authors:  Irenaeus A Adamietz; Oliver Schneider; Rolf-Peter Müller
Journal:  Strahlenther Onkol       Date:  2002-10       Impact factor: 3.621

9.  Factors affecting the use of palliative radiotherapy in Ontario.

Authors:  J Huang; S Zhou; P Groome; S Tyldesley; J Zhang-Solomans; W J Mackillop
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

10.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.